2m 2m 2m 2m 2m 2m 2m
TONIX PHARM HLD (TNXP)
NASDAQ
$11.15-$0.55 (-4.71%)
Price as of Jul 14, 2026 12:48 PM EDT- $186.6MMarket Cap
- -72.64%1-Year Change
- BiotechnologyIndustry
TONIX PHARM HLD (TNXP)
$11.15-$0.55 (-4.71%)
TNXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.71 | ||
Change | -$0.82 (-6.58%) | ||
Open | $12.51 | ||
High | $12.71 | ||
Low | $11.04 | ||
Previous Close | $12.53 | ||
Volume | 1,029,721 | ||
30-Day Average Volume | 546,718 | ||
1-Week Change | -7.91% | ||
1-Month Change | 3.13% | ||
1-Year Change | -72.64% | ||
3-Year Change | -99.80% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 15.9M | ||
Total Assets | $257.9M | ||
Market Cap | $186.6M | ||
Enterprise Value | $1.1M | ||
Period: QTR TTM FY | |||
Revenue | $6.9M | ||
Net Income | -$40.2M | ||
Free Cash Flow | -$44.0M | ||
EBIT | -$40.2M | ||
EBITDA | -$39.6M | ||
Net Working Capital | $177.5M | ||
EPS | -$2.93 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 0 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 100 | ||
Last Split Date | 02/05/2025 | ||
Earnings & Revenue